All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Proteasome inhibitors bind to the proteasome and prevent degradation of multiple proteins involved in various signaling cascades. In lymphomas, the accumulation of unfolded proteins in the endoplasmic reticulum triggers several pro-apoptotic factors and cell stress, thereby inducing apoptosis. Typical examples of proteasome inhibitors are bortezomib and carfilzomib.